EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma

Vincent Tambay iD, Valérie-Ann Raymond, Laure Voisin, Sylvain Meloche iD, Marc Bilodeau iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Vincent Tambay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Hépatologie cellulaire, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Glutamine, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chaire de recherche en hépatologie Novartis - Fondation canadienne du foie de l'Université de Montréal, Canadian Cancer Society Research Institute, Chaire de recherche en hépatologie Novartis—Fondation canadienne du foie de l’Université de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is the most prevalent primary liver malignancy and is a major cause of cancer-related mortality in the world. This study aimed to characterize glutamine amino acid transporter expression profiles in HCC compared to those of normal liver cells. In vitro and in vivo models of HCC were studied using qPCR, whereas the prognostic significance of glutamine transporter expression levels within patient tumors was analyzed through RNAseq. Solute carrier (SLC) 1A5 and SLC38A2 were targeted through siRNA or gamma-p-nitroanilide (GPNA). HCC cells depended on exogenous glutamine for optimal survival and growth. Murine HCC cells showed superior glutamine uptake rate than normal hepatocytes (p < 0.0001). HCC manifested a global reprogramming of glutamine transporters compared to normal liver: SLC38A3 levels decreased, whereas SLC38A1, SLC7A6, and SLC1A5 levels increased. Also, decreased SLC6A14 and SLC38A3 levels or increased SLC38A1, SLC7A6, and SLC1A5 levels predicted worse survival outcomes (all p < 0.05). Knockdown of SLC1A5 and/or SLC38A2 expression in human Huh7 and Hep3B HCC cells, as well as GPNA-mediated inhibition, significantly decreased the uptake of glutamine; combined SLC1A5 and SLC38A2 targeting had the most considerable impact (all p < 0.05). This study revealed glutamine transporter reprogramming as a novel hallmark of HCC and that such expression profiles are clinically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGlutamineGene Expression Regulation, NeoplasticHumansAnimalsPrognosisMiceCell Line, TumorMinor Histocompatibility AntigensMaleFemaleCarrier ProteinsAmino Acid Transport System ASC

Stichwörter der Autor:innen

glutaminehepatocellular carcinomalivermetabolic reprogrammingtransporters

Substanzen

GlutamineSLC1A5 protein, humanMinor Histocompatibility Antigensglutamine transport proteinsCarrier ProteinsAmino Acid Transport System ASC

Autor:innen und Institutionen

  • Laboratoire d'Hépatologie cellulaire, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada.
  • Institut de Recherche en Immunologie et en Cancérologie de l'Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, QC H3C 3J7, Canada.
  • Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada.

ORCID-Profile: Vincent Tambay, Sylvain Meloche, Marc Bilodeau

Förderung

  • Chaire de recherche en hépatologie Novartis - Fondation canadienne du foie de l'Université de Montréal
  • Canadian Cancer Society Research Institute
  • Chaire de recherche en hépatologie Novartis—Fondation canadienne du foie de l’Université de Montréal

Zitieren

APA

Tambay, V., Raymond, V. A., Voisin, L., Meloche, S., & Bilodeau, M. (2024). Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147558

Vancouver

Tambay V, Raymond VA, Voisin L, Meloche S, Bilodeau M. Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147558

BibTeX
@article{Tambay2024,
  author = {Tambay, Vincent and Raymond, Valérie-Ann and Voisin, Laure and Meloche, Sylvain and Bilodeau, Marc},
  title = {Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147558}
}
Kostenlos starten →